Is a four-week hormone suspension necessary for thyroid remnant ablation in low and intermediate risk patients? A pilot study with quality-of-life assessment von Santos, Poliane A.L., Flamini, Maria E.D.M., Mourato, Felipe A., Lima, Fernando R.A., Santos, Joelan A.L., Lima, Fabiana F., Albuquerque, Estelita T.B., De Freitas, Alexandra C., Brandão, Simone C.S.

Volltext